Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Bellamine A, Mangla AT, Nes WD, Waterman MR (1999) Proc Natl Acad Sci U S A 96: 8937-42 Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Podust LM, Poulos TL, Waterman MR (2001) Proc Natl Acad Sci U S A 98: 3068-73 Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth. Lepesheva GI, Ott RD, Hargrove TY, Kleshchenko YY, Schuster I, Nes WD, Hill GC, Villalta F, Waterman MR (2007) Chem Biol 14: 1283-93 Estriol bound and ligand-free structures of sterol 14alpha-demethylase. Podust LM, Yermalitskaya LV, Lepesheva GI, Podust VN, Dalmasso EA, Waterman MR (2004) Structure 12: 1937-45 Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase. Konkle ME, Hargrove TY, Kleshchenko YY, von Kries JP, Ridenour W, Uddin MJ, Caprioli RM, Marnett LJ, Nes WD, Villalta F, Waterman MR, Lepesheva GI (2009) J Med Chem 52: 2846-53 Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition. Friggeri L, Hargrove TY, Rachakonda G, Williams AD, Wawrzak Z, Di Santo R, De Vita D, Waterman MR, Tortorella S, Villalta F, Lepesheva GI (2014) J Med Chem 57: 6704-17 Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors. Friggeri L, Hargrove TY, Wawrzak Z, Guengerich FP, Lepesheva GI (2019) J Med Chem 62: 10391-10401 Cyclic adenosine 3',5'-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids. Rozman D, Fink M, Fimia GM, Sassone-Corsi P, Waterman MR (1999) Mol Endocrinol 13: 1951-62 Elevated expression of lanosterol 14alpha-demethylase (CYP51) and the synthesis of oocyte meiosis-activating sterols in postmeiotic germ cells of male rats. Strömstedt M, Waterman MR, Haugen TB, Taskén K, Parvinen M, Rozman D (1998) Endocrinology 139: 2314-21 Novel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream forms. Nes CR, Singha UK, Liu J, Ganapathy K, Villalta F, Waterman MR, Lepesheva GI, Chaudhuri M, Nes WD (2012) Biochem J 443: 267-77 Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity. Hargrove TY, Wawrzak Z, Alexander PW, Chaplin JH, Keenan M, Charman SA, Perez CJ, Waterman MR, Chatelain E, Lepesheva GI (2013) J Biol Chem 288: 31602-15 Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum. Hargrove TY, Wawrzak Z, Liu J, Nes WD, Waterman MR, Lepesheva GI (2011) J Biol Chem 286: 26838-48 Crystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infections. Lepesheva GI, Park HW, Hargrove TY, Vanhollebeke B, Wawrzak Z, Harp JM, Sundaramoorthy M, Nes WD, Pays E, Chaudhuri M, Villalta F, Waterman MR (2010) J Biol Chem 285: 1773-80 Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis. Matsuura K, Yoshioka S, Tosha T, Hori H, Ishimori K, Kitagawa T, Morishima I, Kagawa N, Waterman MR (2005) J Biol Chem 280: 9088-96 Folding requirements are different between sterol 14alpha-demethylase (CYP51) from Mycobacterium tuberculosis and human or fungal orthologs. Lepesheva GI, Podust LM, Bellamine A, Waterman MR (2001) J Biol Chem 276: 28413-20 Structural analyses of sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ, Schotzinger RJ, York JD, Guengerich FP, Lepesheva GI (2017) J Biol Chem 292: 6728-6743 In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi. Soeiro Mde N, de Souza EM, da Silva CF, Batista Dda G, Batista MM, Pavão BP, Araújo JS, Aiub CA, da Silva PB, Lionel J, Britto C, Kim K, Sulikowski G, Hargrove TY, Waterman MR, Lepesheva GI (2013) Antimicrob Agents Chemother 57: 4151-63 Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol. Hargrove TY, Wawrzak Z, Liu J, Waterman MR, Nes WD, Lepesheva GI (2012) J Lipid Res 53: 311-20 Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology. Bellamine A, Lepesheva GI, Waterman MR (2004) J Lipid Res 45: 2000-7 Structural requirements for substrate recognition of Mycobacterium tuberculosis 14 alpha-demethylase: implications for sterol biosynthesis. Bellamine A, Mangla AT, Dennis AL, Nes WD, Waterman MR (2001) J Lipid Res 42: 128-36 Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design. Hargrove TY, Friggeri L, Wawrzak Z, Sivakumaran S, Yazlovitskaya EM, Hiebert SW, Guengerich FP, Waterman MR, Lepesheva GI (2016) J Lipid Res 57: 1552-63 Lanosterol 14alpha-demethylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol. Majdic G, Parvinen M, Bellamine A, Harwood HJ, Ku WW, Waterman MR, Rozman D (2000) J Endocrinol 166: 463-74 Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Lepesheva GI, Waterman MR (2011) Curr Top Med Chem 11: 2060-71 CYP51 from Trypanosoma brucei is obtusifoliol-specific. Lepesheva GI, Nes WD, Zhou W, Hill GC, Waterman MR (2004) Biochemistry 43: 10789-99 Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions. McLean KJ, Warman AJ, Seward HE, Marshall KR, Girvan HM, Cheesman MR, Waterman MR, Munro AW (2006) Biochemistry 45: 8427-43 Conservation in the CYP51 family. Role of the B' helix/BC loop and helices F and G in enzymatic function. Lepesheva GI, Virus C, Waterman MR (2003) Biochemistry 42: 9091-101 The three human cytochrome P450 lanosterol 14 alpha-demethylase (CYP51) genes reside on chromosomes 3, 7, and 13: structure of the two retrotransposed pseudogenes, association with a line-1 element, and evolution of the human CYP51 family. Rozman D, Strömstedt M, Waterman MR (1996) Arch Biochem Biophys 333: 466-74 The ubiquitously expressed human CYP51 encodes lanosterol 14 alpha-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Strömstedt M, Rozman D, Waterman MR (1996) Arch Biochem Biophys 329: 73-81 Lanosterol 14alpha-demethylase (CYP51) and spermatogenesis. Rozman D, Waterman MR (1998) Drug Metab Dispos 26: 1199-201 Substrate recognition sites in 14alpha-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51. Podust LM, Stojan J, Poulos TL, Waterman MR (2001) J Inorg Biochem 87: 227-35 Structure and mapping of the human lanosterol 14alpha-demethylase gene (CYP51) encoding the cytochrome P450 involved in cholesterol biosynthesis; comparison of exon/intron organization with other mammalian and fungal CYP genes. Rozman D, Strömstedt M, Tsui LC, Scherer SW, Waterman MR (1996) Genomics 38: 371-81 Preimplantation mouse blastocysts fail to express CYP genes required for estrogen biosynthesis. Strömstedt M, Keeney DS, Waterman MR, Paria BC, Conley AJ, Dey SK (1996) Mol Reprod Dev 43: 428-36 Sterol 14 alpha-demethylase, an abundant and essential mixed-function oxidase. Waterman MR, Lepesheva GI (2005) Biochem Biophys Res Commun 338: 418-22 Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. Lamb DC, Kelly DE, Waterman MR, Stromstedt M, Rozman D, Kelly SL (1999) Yeast 15: 755-63
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.